Health & Medicine

6

Ebola Prompts Precautions at Philly Universities

September 5, 2014

Penn’s student health clinicians are included amongst area universities taking precautionary steps aligned with the guidelines set by the government’s health watchdog.

Article Source: Philadelphia Tribune
facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194September 9, 2014

Penn Study Finds Genetic Mutations Linked With Ethnic Disparities in Cancer

blurb: 
In a new study published in the journal BMC Medical Genomics, researchers at the University of Pennsylvania identified more than 30 previously undescribed mutations in important regulatory molecules called microRNAs. Many of these mutations influence whether a person develops cancer or the severity of the disease.

One of the goals of genome sequencing is to identify genetic mutations associated with increased susceptibility to disease. Yet by and large these discoveries have been made in people of European or Asian ancestry, resulting in an incomplete picture of global genetic variation in disease vulnerability.

facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604September 9, 2014

Penn Research Shows How Brain Can Tell Magnitude of Errors

University of Pennsylvania researchers have made another advance in understanding how the brain detects errors caused by unexpected sensory events. This type of error detection is what allows the brain to learn from its mistakes, which is critical for improving fine motor control.  

facebook twitter google print email
Media Contact:Anna Duerr | anna.duerr@uphs.upenn.edu | 215-349-8369September 3, 2014

Penn Study Shows Better Outcomes for Sepsis Patients Treated in Hospitals with Higher Volume of Cases

Patients with sepsis, one of the most time-sensitive and hard-to-detect illnesses in medicine, are more likely to survive the life-threatening condition when treated at a hospital that sees a higher volume of sepsis cases.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194September 4, 2014

Plant-based Research at Penn Prevents Complication of Hemophilia Treatment in Mice

blurb: 
In a new study, researchers from the University of Pennsylvania School of Dental Medicine and the University of Florida College of Medicine teamed up to develop a strategy to prevent a common complication of hemophilia treatment.

Normal 0 false false

facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604September 3, 2014

Tenth PennApps Hackathon Ready to Award $30,000 in Prizes to World’s Top Coders

In a hackathon, teams of coders compete against each other and the clock, working night and day to produce the best possible software and hardware applications under a tight deadline.

WHO

1,200 Top Collegiate Hackers

Massimo Banzi
Co-Founder, Arduino

David Pakman
Partner, Venrock

WHAT

The 10th edition of 48-hour PennApps Hackathon, the largest and most prestigious student-run hackathon in the world, with more than $30,000 in prizes for best software and hardware applications

Public expo of projects created during the weekend

Awards ceremony

WHERE

Hacking begins: Friday, Sept. 12, 7:30 p.m.

Expo: Sunday, Sept. 14, 10:30 a.m.-1:30 p.m.

Awards ceremony: Sunday, Sept. 14, 2 p.m.

WHERE

University of Pennsylvania

Hacking:
Engineering Quad
220 S. 33rd St.

and  

Education Commons
233 S. 33rd St.

Expo:
The Palestra
235 S. 33rd St.

Award Ceremony:
Irvine Auditorium
3401 Spruce St. 

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658August 26, 2014

Drug for Rare Blood Disorder Developed at Penn Receives Orphan Drug Status from European Union

A Penn Medicine-developed drug has received orphan status in Europe this week for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare, life-threatening disease that causes anemia due to destruction of red blood cells and thrombosis.

facebook twitter google print email
Media Contact:Karen Kreeger | Karen.kreeger@uphs.upenn.edu | 215-349-5658August 28, 2014

Penn Medicine Study: Attacking a Rare Disease at its Source With Gene Therapy

Treating the rare disease MPS I is a challenge. MPS I, caused by the deficiency of a key enzyme called IDUA, eventually leads to the abnormal accumulation of certain molecules and cell death. 

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194August 28, 2014

Penn-NIH Team Discovers New Type of Cell Movement in 3D Matrix

blurb: 
In a new study from the University of Pennsylvania and National Institute of Dental and Craniofacial Research, scientists used an innovative technique to study how cells move in a three-dimensional matrix, similar to the structure of certain tissues, such as the skin. They discovered an entirely new type of cell movement whereby the nucleus helps propel cells through the matrix like a piston in an engine, generating pressure that thrusts the cell’s plasma membrane forward.

For decades, researchers have used petri dishes to study cell movement. These classic tissue culture tools, however, only permit two-dimensional movement, very different from the three-dimensional movements that cells make in a human body.

Lively Accounts Examining Death

August 25, 2014

The Perelman School of Medicine’s David Casarett discusses his book Shocked: Adventures in Bringing Back the Recently Dead.

Article Source: New York Times